227 related articles for article (PubMed ID: 12016866)
1. [The estrogenic activities of 2-[3-estrone-N-ethyl-piperazine-methyl]tetracycline(XW630)--a new compound with anti-osteoporosis activity].
Mo Z; Jiao X; Su H; Zheng H; Weng L
Yao Xue Xue Bao; 1998 Sep; 33(9):645-9. PubMed ID: 12016866
[TBL] [Abstract][Full Text] [Related]
2. Effects of 2-[3-estrone-N-ethyl-piperazine-methyl]tetracycline (XW630) on osteoporosis in ovariectomized rats.
Sun L; Qiu MC; Weng LL; Zheng H; Liu JS
Acta Pharmacol Sin; 2000 Mar; 21(3):200-4. PubMed ID: 11324415
[TBL] [Abstract][Full Text] [Related]
3. C-mycprotein expression upregulated by 2-(3-estrone-N-ethyl piperazine-methyl) tetracycline in bone.
Weng LL; Li LZ; Zhang YL; Lou RL; Zheng H
Yao Xue Xue Bao; 2002 Oct; 37(10):771-4. PubMed ID: 12567859
[TBL] [Abstract][Full Text] [Related]
4. [Study of XW630 in promoting estrogen receptor expression in ovariectomized rats].
Fei W; Wang D; Zheng H; Weng L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jan; 19(1):101-4. PubMed ID: 11951493
[TBL] [Abstract][Full Text] [Related]
5. Effects of XW630 on cell proliferation, iNOS activity, and cGMP content in human osteoblast-like cell line TE85.
Sun L; Weng LL; Zheng H; Liu JS
Acta Pharmacol Sin; 2000 Mar; 21(3):261-4. PubMed ID: 11324428
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of XW630 on estrogen receptor messenger RNA expression in osteoblasts].
Wang D; Fei W; Zheng H; Weng L; Deng L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):260-3. PubMed ID: 12856593
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
8. [Properties of alkylating derivatives of estrogens].
Morozova TM; Merkulova TI; Martynov V; Iaguzhinskaia VP; Shkodinskaia EN
Eksp Onkol; 1984; 6(2):50-4. PubMed ID: 6510335
[TBL] [Abstract][Full Text] [Related]
9. In vivo estrogenic and antiestrogenic activity of phenolphthalein and derivative compounds.
Nieto A; García C; López de Haro MS
Biochem Int; 1990; 21(2):305-11. PubMed ID: 2403370
[TBL] [Abstract][Full Text] [Related]
10. Effects of XW630 on bone formation in ovariectomized rats and in human osteoblast-like cells.
Sun L; Qiu M; Weng L; Zheng H; Liu J
Chin Med Sci J; 2000 Mar; 15(1):8-13. PubMed ID: 12899391
[TBL] [Abstract][Full Text] [Related]
11. Assessment of estrogenic activity in some common essential oil constituents.
Howes MJ; Houghton PJ; Barlow DJ; Pocock VJ; Milligan SR
J Pharm Pharmacol; 2002 Nov; 54(11):1521-8. PubMed ID: 12495555
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, estrogen receptor binding affinity and biological evaluation of some 2-substituted estrone derivatives.
Omar AM; AboulWafa OM; Labouta IM; el-Tombary AA; el-Mallah AI
Farmaco; 1997 Apr; 52(4):219-25. PubMed ID: 9241826
[TBL] [Abstract][Full Text] [Related]
13. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase.
Ciobanu LC; Luu-The V; Martel C; Labrie F; Poirier D
Cancer Res; 2003 Oct; 63(19):6442-6. PubMed ID: 14559834
[TBL] [Abstract][Full Text] [Related]
15. Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors.
Di Carlo F; Conti G; Reboani C; Racca S
Farmaco Sci; 1980 May; 35(5):425-9. PubMed ID: 7450040
[TBL] [Abstract][Full Text] [Related]
16. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene.
Dwivedi A; Basu R; Chowdhury SR; Goyal N
Contraception; 2005 Jun; 71(6):458-64. PubMed ID: 15914137
[TBL] [Abstract][Full Text] [Related]
17. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and study of B-nor-8-isoanalogs of steroid estrogens].
Shavva AG; Selivanov SI; Starova GL; Boronoeva TR; Ishchenko IV; Gluzdikov IA; Sharetskiĭ AN; Isaeva VG; Surinov BP
Bioorg Khim; 2002; 28(3):242-50. PubMed ID: 12077850
[TBL] [Abstract][Full Text] [Related]
19. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
Martel C; Labrie C; Bélanger A; Gauthier S; Mérand Y; Li X; Provencher L; Candas B; Labrie F
Endocrinology; 1998 May; 139(5):2486-92. PubMed ID: 9564862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
